Section one: Contracting authority/entity
one.1) Name and addresses
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
1 South Gyle Crescent
Edinburgh
EH12 9EB
Telephone
+44 1312756000
Country
United Kingdom
NUTS code
UKM - Scotland
Internet address(es)
Main address
http://www.nss.nhs.scot/browse/procurement-and-logistics
Buyer's address
https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Compounded Aseptic Medicines
Reference number
NP38619
two.1.2) Main CPV code
- 33600000 - Pharmaceutical products
two.1.3) Type of contract
Supplies
two.1.4) Short description
This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags
to NHS Scotland.
two.1.6) Information about lots
This contract is divided into lots: Yes
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £105,813,953
two.2) Description
two.2.1) Title
Compounded Aseptic Medicines
Lot No
1
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant
to the new Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,
Atezolizumab
Cetuximab
Doxorubicin
Epirubicin
Infliximab (Inflectra®), (Remicade®), (Remsima®)
Nivolumab
Pembrolizumab
Pertuzumab
The Authority intends to awarded all presentations within this Lot to a single supplier.
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Compounded Aseptic Medicines
Lot No
2
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant
to New Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,
Cyclophosphamide
Fluorouracil
Irinotecan
Methotrexate
Rituximab (Mabthera®), (Rixathon®), (Truxima®)
The Authority intends to awarded all presentations within this Lot to a single supplier
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Compounded Aseptic Medicines
Lot No
3
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant
to New Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,
Bortezomib
Carboplatin
Cisplatin
Docetaxel
Gemcitabine
Oxaliplatin
Trastuzumab (Herceptin®), (Herzuma®)
Vincristine
The Authority intends to awarded all presentations within this Lot to a single supplier.
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2) Description
two.2.1) Title
Compounded Aseptic Medicines - All Other Presentations
Lot No
4
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKM - Scotland
Main site or place of performance
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant
to New Public Bodies (Joint Working) Scotland Act 2014.
two.2.4) Description of the procurement
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,
The molecules included in this Lot are,
Bevacizumab
Cytarabine
Infliximab (Zessly®)
Insulin
Methotrexate
Natalizumab
Nivolumab
Paclitaxel
Pemetrexed
Tocilizumab
Trastuzumab (Kanjinti®), (Ontruzant®)
Trastuzumab Subcutaneous
Vedolizumab
Each product line will be treated as an individual Lot and awarded as an unranked multi-supplier framework.
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector
during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with
Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015
four.1.3) Information about a framework agreement
The procurement involves the establishment of a framework agreement
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract/concession
Lot No
1
Title
Compounded Aseptic Medicines
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
24 February 2025
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
Baxter Healthcare Ltd
Wallingford Road, Compton,
Newbury, Berkshire
RG20 7QW
Telephone
+44 1635206000
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
No
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: £13,653,346
Section five. Award of contract/concession
Lot No
2
Title
Compounded Aseptic Medicines
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
24 February 2025
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
Qualasept Limited t/a Bath ASU
Unit A15 Fiveways Light Industrial Estate, Westwells Road,
Corsham
SN13 9RG
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
No
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: £1,565,729
Section five. Award of contract/concession
Lot No
3
Title
Compounded Aseptic Medicines
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
24 February 2025
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
Baxter Healthcare Ltd
Wallingford Road, Compton,
Newbury, Berkshire
RG20 7QW
Telephone
+44 1635206000
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
No
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: £1,064,777
Section five. Award of contract/concession
Lot No
4
Title
Compounded Aseptic Medicines - All Other Presentations
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
24 February 2025
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: Yes
five.2.3) Name and address of the contractor/concessionaire
Baxter Healthcare Ltd
Wallingford Road, Compton,
Newbury, Berkshire
RG20 7QW
Telephone
+44 1635206000
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
No
five.2.3) Name and address of the contractor/concessionaire
Qualasept Limited t/a Bath ASU
Unit A15 Fiveways Light Industrial Estate, Westwells Road,
Corsham
SN13 9RG
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
No
five.2.3) Name and address of the contractor/concessionaire
ITH Pharma Limited
Unit 4 Premier Park, Premier Park Road
London
NW10 7NZ
Telephone
+44 2088388260
Fax
+44 2088388261
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor/concessionaire is an SME
No
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: £5,085,024
Section six. Complementary information
six.3) Additional information
The estimated value(s) of the Framework Agreement referred to in Section V.2.4 (comprising three (4) Lots) cover(s) the twelve (12)
month duration of the proposed modification period of the Framework Agreement.
NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=790498.
(SC Ref:790498)
six.4) Procedures for review
six.4.1) Review body
Sheriff Court House
27 Chambers Street
Edinburgh
EH1 1LB
Telephone
+44 1312252525
Country
United Kingdom
six.4.3) Review procedure
Precise information on deadline(s) for review procedures
The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication
method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority
proposes to conclude the relevant framework agreement.
The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering
into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings
to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include
the setting aside of the decision to award the framework agreement to the winning tenderer.
The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework
agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be
established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited
to the award of damages.